Clinical Trial Update: A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated intravenous Oncaspar (pegaspargase) and intravenous Gemzar (gemcitabine) in patients with solid tumors and lymphoma; the study was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Gemzar (gemcitabine)
• Oncaspar (pegaspargase)

Snippet

Sponsor: Enzon Pharmaceuticals, Inc. | Conditions: Tumors, Lymphoma | Phase 1 | Status: TERMINATED